Fine Foods & Pharmaceuticals Ntm
Contract development & manufacturing of oral solids for pharma, nutraceutical & cosmetic sectors.
FF | XMIL
Overview
Corporate Details
- ISIN(s):
- IT0005215329 (+1 more)
- LEI:
- 8156009111DEE8553765
- Country:
- Italy
- Address:
- VIA BERLINO, 39 (ZINGONIA), 24040 VERDELLINO
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Fine Foods & Pharmaceuticals Ntm is an integrated Contract Sales and Development Manufacturing Organization (CSDMO) that serves as a strategic manufacturing partner for third parties. The company specializes in the development and production of oral solid forms for the pharmaceutical and nutraceutical sectors, as well as products for the cosmetics, medical device, and biocide industries. It leverages over 100 manufacturing lines and a strong focus on scientific innovation, with a significant portion of its workforce dedicated to science and R&D. Fine Foods emphasizes technological excellence, quality, reliability, and a long-standing commitment to ESG principles to support its clients' growth objectives.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-11 15:15 |
Regulatory News Service
Interim Financial Report as of 30 September 2025
|
Italian | 448.5 KB | ||
| 2025-11-10 10:42 |
Transaction in Own Shares
INFORMATIVA SULL’ACQUISTO AZIONI PROPRIE PERIODO 3 NOVEMBRE – 7 NOVEMBRE 2025 /…
|
Italian | 463.4 KB | ||
| 2025-11-06 15:18 |
Regulatory News Service
Resoconto intermedio di gestione al 30 settembre 2025
|
Italian | 400.6 KB | ||
| 2025-11-06 13:38 |
Earnings Release
Fine Foods confirms growth trajectory: revenue +7%, Adjusted EBITDA was €30.5 m…
|
English | 644.7 KB | ||
| 2025-11-06 13:37 |
Earnings Release
Fine Foods consolida il percorso di crescita: ricavi +7%, EBITDA Adj. a €30,5 m…
|
Italian | 639.5 KB | ||
| 2025-11-04 10:09 |
Director's Dealing
Allegato 3F / Annex 3F
|
Italian | 28.7 KB | ||
| 2025-11-03 11:31 |
Transaction in Own Shares
INFORMATIVA SULL’ACQUISTO AZIONI PROPRIE PERIODO 27 OTTOBRE – 31 OTTOBRE 2025 …
|
Italian | 471.5 KB | ||
| 2025-10-27 11:19 |
Transaction in Own Shares
INFORMATIVA SULL’ACQUISTO AZIONI PROPRIE PERIODO 20 OTTOBRE – 24 OTTOBRE 2025 /…
|
Italian | 449.3 KB | ||
| 2025-10-20 11:15 |
Transaction in Own Shares
INFORMATIVA SULL’ACQUISTO AZIONI PROPRIE PERIODO 13 OTTOBRE – 17 OTTOBRE 2025 …
|
Italian | 461.5 KB | ||
| 2025-10-13 11:03 |
Transaction in Own Shares
INFORMATIVA SULL’ACQUISTO AZIONI PROPRIE PERIODO 6 OTTOBRE – 10 OTTOBRE 2025 /…
|
Italian | 425.3 KB | ||
| 2025-10-06 11:30 |
Transaction in Own Shares
INFORMATIVA SULL’ACQUISTO AZIONI PROPRIE PERIODO 29 SETTEMBRE – 3 OTTOBRE 2025…
|
Italian | 444.9 KB | ||
| 2025-10-02 11:51 |
Director's Dealing
Allegato 3F / Annex 3F
|
Italian | 28.8 KB | ||
| 2025-09-29 12:11 |
Transaction in Own Shares
INFORMATIVA SULL’ACQUISTO AZIONI PROPRIE PERIODO 22 SETTEMBRE – 26 SETTEMBRE 2…
|
Italian | 452.8 KB | ||
| 2025-09-22 11:05 |
Transaction in Own Shares
INFORMATIVA SULL’ACQUISTO AZIONI PROPRIE PERIODO 15 SETTEMBRE – 19 SETTEMBRE 2…
|
Italian | 468.2 KB | ||
| 2025-09-15 12:06 |
Transaction in Own Shares
INFORMATIVA SULL’ACQUISTO AZIONI PROPRIE PERIODO 8 SETTEMBRE – 12 SETTEMBRE 202…
|
Italian | 458.0 KB |
Automate Your Workflow. Get a real-time feed of all Fine Foods & Pharmaceuticals Ntm filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Fine Foods & Pharmaceuticals Ntm
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Fine Foods & Pharmaceuticals Ntm via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
